Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
Gilead Sciences, Inc. (NASDAQ: GILD) and Trianni, Inc. (“TRIANNI”) today announced that the companies have entered into a license agreement that grants Gilead the use of the Trianni transgenic human monoclonal antibody discovery platform to support the company’s drug discovery efforts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180904005088/en/
"We look forward to integrating Trianni’s technology into our research and development program," said Bill Lee, PhD, Executive Vice President of Research, Gilead. "This platform will help enhance our ability to discover human antibodies and to develop new therapies in areas of unmet medical need.”
"Trianni is very happy that Gilead has chosen the Trianni discovery platform," said Matthias Wabl, PhD, Chairman, President and CEO of Trianni. "We are confident that the cutting-edge genomic design of the Trianni discovery platform, which combines the complete human antibody repertoire with wild-type mouse immune responses to any target antigen, will nicely complement Gilead’s drug discovery programs."
No financial details were disclosed.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
About Trianni, Inc.
Trianni, Inc. is a privately held biotech company specializing in antibody discovery technology. Trianni's lead technology is a next-generation transgenic discovery platform enabling efficient generation of fully-human monoclonal antibodies. The design of the Trianni discovery platform leverages advances in DNA synthesis and genomic modification technology. Trianni is headquartered in South San Francisco, CA. Additional information about Trianni is available through its corporate website, www.trianni.com.
Gilead Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this licensing arrangement. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.
Sung Lee, 650-524-7792
Nathan Kaiser, 650-522-1853
Mandy Boyd, 415-231-0256 [o]
Director of Marketing
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Oxford Nanopore Prevails in Patent Ruling against Pacific Biosciences22.1.2019 17:04 | Pressemelding
Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that the claims to a single molecule sequencing process were unsupported in the application and that the application only supported a template-directed synthesis sequencing method. As Pacific Biosciences were unwilling to accept this change, the patent was revoked. The decision by the EPO is consistent with a recent decision by the International Trade Commission (ITC) to limit the claims of a related Pacific Biosciences US patent to template-directed synthesis. View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005733/en/ Contact information Oxford Nanopore Zoe McDougall email@example.com Website: https://nanoporetech.com/
Värde Partners Names New Partners, Additional Deputy CIO22.1.2019 17:00 | Pressemelding
Värde Partners is pleased to announce the appointment of Elena Lieskovska and Haseeb Malik to Partner, and the promotion of Brad Bauer to Deputy Chief Investment Officer. “It gives me great pleasure to announce the promotions of three individuals who have been instrumental in the success of our firm through their investing expertise, leadership and integrity,” said George Hicks, Co-Founder and CEO of Värde Partners. “Brad, Elena and Haseeb have all made significant contributions to Värde’s culture, global presence, and, most importantly, delivering returns to our investors.” Based in London, Elena is Head of European Financial Services, responsible for Värde’s private equity investments in specialty finance companies and related businesses in Europe. She joined the firm in 2008 and over the past decade has helped establish the firm as a leader in the consumer finance space, building large credit platforms. Haseeb is Head of Asia Corporate and Traded Credit. Based in Singapore since the
Citi Announces Inaugural Green Bond Issuance22.1.2019 17:00 | Pressemelding
Citi today announced the issuance of the firm’s first green bond, further enhancing its commitment to environmental and climate finance. The bond will fund renewable energy, sustainable transportation, water quality and conservation, energy efficiency and green building projects financed as part of Citi’s $100 billion Environmental Finance Goal. In the deal, which priced on 22nd January 2019, Citi issued €1 billion 3-year fixed rate notes. The transaction marks the first green bond offering from Citigroup Inc. “We are proud to start the year with the launch of our inaugural green bond,” said Jamie Forese, President of Citigroup and Head of the Institutional Clients Group. “This transaction represents an important next step in expanding Citi’s commitment to sustainable growth. This bond also further enhances our green bond expertise, strengthens our partnerships with clients around the world and responds to increasing investor interest in sustainable finance.” In 2015, Citi announced a
NGINX Has Modernized Full API Lifecycle Management22.1.2019 15:44 | Pressemelding
NGINX, Inc., the company based on the popular open source project and offering a suite of technologies designed to develop and deliver modern applications, today announced general availability of its API Management Module. The API Management Module for NGINX Controller is part of the NGINX Application Platform, a modular and integrated set of technologies to help organizations create applications with performance, reliability, security, and scale. The NGINX API management solution enables infrastructure and operations (I&O) teams to define and publish APIs, manage traffic to and secure backend applications, monitor performance issues, and analyze API usage. NGINX API Management Module is built on an innovative architecture that provides three unique benefits: Proven – NGINX combines new control-plane functionality with the raw power and efficiency of NGINX Plus, the industry’s most deployed API gateway. NGINX software powers more than 350 million websites and, according to our 2018 use
800 Kilometers Alone across the Largest Freshwater Lake in the World: BWT Supports Extreme Athlete Ernst Bromeis on his Spectacular Swimming Expedition for Environmental Protection22.1.2019 15:39 | Pressemelding
Clean water is precious. That’s the message that BWT — Europe’s leading water technology company — and extreme athlete Ernst Bromeis hope to spread with a spectacular expedition. Starting July 8, the Swiss athlete will swim 800 kilometers across Lake Baikal, the largest freshwater lake on Earth. BWT will be by his side as initiator and partner for the Lake Baikal project. “We want to give people food for thought and raise awareness of the fact that water is a resource worth protecting. BWT’s water purification solutions help reduce plastic waste and protect the environment with every sip. Consumers can cut their household expenses and do away with the need to lug home water bottles, all while doing their part for the environment. From table water filters to water filter units to faucets and compact water cooler solutions for the home, BWT’s pioneering magnesium technology turns good-quality tap water into outstanding Magnesium Mineralized Water,” says Lutz Hübner, Head of Marketing, BW
Andersen Global Announces Collaboration with Budapest Law Firm22.1.2019 14:30 | Pressemelding
Andersen Global announced a collaboration agreement with Szabo Kelemen & Partners Attorneys, a respected law firm based in Budapest, Hungary. Hungary marks the 38th country in which Andersen Global offers legal services, expanding the international association’s growing presence in Eastern Europe. Andersen Global is now present in more than 46 countries worldwide. Founded over two decades ago, Szabo Kelemen & Partners began as the legal arm of EY in Hungary. The firm has since grown to be the premier law firm in Budapest. The team is comprised of more than 30 professionals with decades of legal experience and international accolades, and will continue to advise local and international clients on tax, corporate and commercial issues in various industries. “We started as part of the Big Four, and over the last several years, as we’ve watched Andersen Global grow and set the client service bar higher, it was fitting and natural that we join forces to provide our clients with the very best